Clinical Trial Update: A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely

View source ↗

Summary

This clinical trial update analyzes available data to determine how closely patients with prostate cancer on second-generation androgen receptor inhibitors adhe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Second generation androgen receptor inhibitors

Snippet

Sponsor: Bayer | Conditions: Prostate Cancer | Status: COMPLETED